AbbVie to Acquire Cerevel Therapeutics for $8.7 Bn to Boost Neurological Drug Portfolio December 11, 2023 Trading in options for Cerevel experienced an unusual surge in the days leading up to the announcement, with significant interest in upside call options.
Gavi Allocates $1 Bn to Accelerate African Vaccine Manufacturing & Access December 11, 2023 Funding for the "African Vaccine Manufacturing Accelerator" comes from residual funds in the COVAX initiative, established during the pandemic to facilitate vaccine distribution to the world's poorest nations.
Dr Reddy’s Signs Pact with Coya Therapeutics for Investigational Therapy of ALS December 8, 2023 Additionally, Dr Reddy’s will make a $7.5 million upfront payment to Coya for the purpose. This arrangement is in addition to the in-licensing agreement with Dr Reddy signed in early 2023.
Jefferson Health Launches Trailblazing LGBTQ+ Elderly Care Program December 7, 2023 The primary objective of this initiative is to address the healthcare needs of the traditionally underserved LGBTQ+ community, specifically older adults.
US-Based CVS Health Revamps Drug Reimbursement Model to Address Rising Costs December 7, 2023 Under the new model, CVS will transition to fixed rates for reimbursements from pharmacy benefit managers (PBMs), aligning with the approach adopted by newer players including Mark Cuban Cost Plus Drugs Co.
West Pharma Launches Vial2Bag Advanced Admixture Device to Enhance Patient Care December 7, 2023 The device is needle-free and is suitable for immediate use. It can optimise the time spent in pharmacy clean rooms and assist in standardising admixture systems to maximise the efficiency of point-of-care nursing.
VinBrain Launches AI-Enabled Solutions to Advance Precision Care December 7, 2023 The freshly launched two solutions DrAid Enterprise Data Solution (EDS) and DrAid Oncology Diagnosis and Treatment (D&T), are focused on centralisation, transformation, and intelligence.
Clarivate Launches VeriSIM Life Translational Index to Enhance Drug Discovery Intelligence December 6, 2023 This integrated workflow aims to offer diverse predictive insights into compound safety and efficacy, including bioavailability, hepatic and renal clearance, clinical toxicity, first-in-human dose, and more.
CVS Health is Now CVS Healthspire as Part of Long Term Growth Strategy December 6, 2023 The rebranding follows the company's recent acquisitions of Signify Health and Oak Street Health, totaling nearly $20 billion.
Indiana Uni Researchers Develop New Tools to Advance Alzheimer's Disease Research December 6, 2023 he novel tools provide a translational approach to assess Alzheimer’s disease progression in animal models and bolster the consortium’s rigorous animal model development and preclinical drug testing pipelines developed to study and treat the disease.
Roche Acquires Carmot Therapeutics in a close to $3.1 Bn Deal to Enter Obesity Drug Market December 6, 2023 The weight loss treatment market has witnessed significant growth, with estimates suggesting it could be valued at up to $140 billion. Novo Nordisk and Eli Lilly currently dominate this space with injectable treatments.
Mayo Clinic Plans $5 Bn Expansion of Minnesota Campus December 6, 2023 As per the expansion plan, Mayo will add five new buildings. Those will be designed to accommodate fresh requirements, with flexibility of changing the rooms from patient to operating rooms.